Targets of perturbagens

Perturbagen ID Perturbagen Reference Target Number Response ID
CID57601 Cabometyx; Cometriq DrugBank 3  NA
CID57602 (±)-2-hydroxypropanoic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; Acidum lacticum; Cheongin haejanghwan; Cheongin haewoohwan; Cheongin samrakhwan; Curel alpha hydroxy dry skin lotion; Dl- lactic acid; Dl-lactic acid; Dl-milchsäure; Fresh morning bifidus bifidus; Herbal stemcell aha peel; Lactate 1-2-3 injection; Lactate chloride dextrose inj; Lacticum acidum; Milchsäure; Milk acid; Penederm cream; Penederm lotion; Rac-lactic acid; Sodium lactate; Α-hydroxypropanoic acid; Α-hydroxypropionic acid DrugBank 26  NA
CID57603 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)pentitol; 6,7-dimethyl-9-d-ribitylisoalloxazine; 7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; 7,8-dimethyl-10-ribitylisoalloxazine; B 6 plus; B-combo; B-plex 100; B6 plus tab; Bio-fen; Cc ii; Chela potassium plus; Coenzyme q10 isotonix vitamin and mineral supplement; Complex 5 - pwr; D'pantothenic acid-b1-b2 tab; E101; Floradix formula liq; Formula adr-vitamin b2,b6 w calpan tab; Formula dpr; Geritol liquid; Globucel - methode; Hemarexin amp; Hemarexin liquid and drinkable ampoules; Isotonix calcium plus formula; Lactoflavin; Lactoflavine; Maltlevol liq; Methaver; Neo-bex; Neo-bex injectable; Photrexa; Photrexa viscous; Potassium plus vit b complex; Riboflavina; Riboflavine; Riboflavinum; Vitamin and mineral supplement - liq; Vitamin b complex; Vitamin b-2; Vitamin b2; Vitamin g DrugBank; STITCH 54  NA
CID57604 Ibritumomab; Mab murine (igg1) anti p19437 (cd20_mouse); Zevalin DrugBank 12  NA
CID57605 Cetrimonium cation; Cetrimonium ion; Cetyl-trimethyl-ammonium; Cetyltrimethylammonium; Cetyltrimethylammonium cation; Cetyltrimethylammonium ion; Hexadecyltrimethylammonium; Hexadecyltrimethylammonium cation; Hexadecyltrimethylammonium ion; N,n,n-trimethyl-1-hexadecanaminium; Trimethylhexadecylammonium DrugBank 2  NA
CID57606 (2s)-2-amino-4-methylpentanoic acid; (2s)-alpha-2-amino-4-methylvaleric acid; (2s)-alpha-leucine; (s)-(+)-leucine; (s)-leucine; 2-amino-4-methylvaleric acid; L; L-leucin; L-leuzin; Leu; Leucine DrugBank; STITCH 160  NA
CID57607 Alendronate; (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid); (4-amino-1-hydroxybutylidene)bisphosphonic acid; 4-amino-1-hydroxybutane-1,1-diphosphonic acid; Abdp; Accel-alendronate; Ach-alendronate; Acide alendronique; Acido alendronico; Acidum alendronicum; Act alendronate; Alendronate sodium; Alendronate-70; Apo-alendronate; Auro-alendronate; Binosto; Dom-alendronate; Dom-alendronate-fc; Fosamax; Gen-alendronate; Jamp-alendronate; Mint-alendronate; Mylan-alendronate; Phl-alendronate; Pms-alendronate; Pms-alendronate-fc; Q-alendronate; Ran-alendronate; Ratio alendronate; Riva alendronate; Sandoz alendronate; Teva-alendronate; Van-alendronate DrugBank; CLUE; STITCH 8  RID01267 RID01268 RID01269
CID57608 Bexxar therapy DrugBank 11  NA
CID57609 Canagliflozin anhydrous; Invokana DrugBank 2  NA
CID57610 Fmm; Gw 572016; Lapatinib tosilate hydrate; N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine; N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; Tykerb DrugBank 2  NA